Recombinant streptomyces nodosus with high yield of amphotericin B and applications of recombinant streptomyces nodosus
An amphotericin and Streptomyces technology, applied to recombinant Streptomyces tuberculosis with high production of amphotericin B and its application field, can solve problems such as loss of activity, and achieve the advantages of increasing production capacity and output value, reducing the content of by-products, and shortening fermentation time. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Example 1 Carrier pJTU1278 conjugative transfer transformation recipient strain Streptomyces tuberculosis
[0044] A) Preparation of E.coil ET12567 / puz8002 donor bacteria containing vector:
[0045] The vector pJTU1278 was introduced into E.coil ET12567 / puz8002 competent cells, and ampicillin (Amp + , 100μg / mL), chloramphenicol (Cm + , 25μg / mL), kanamycin (Kan + , 50 μg / mL) resistance screening, positive transformants were picked, verified by M13 upstream and downstream primer colony PCR, and the sequencing results proved that the vector pJTU1278 was transformed into E.coilET12567 / puz8002. The specific operation is as follows:
[0046] E.coil ET12567 / puz8002 competent preparation method is as follows:
[0047] Take the E.coil ET12567 / puz8002 Escherichia coli liquid from the glycerol cryopreservation tube of the strain, draw the line on the LB plate, and cultivate it at 37°C until a single colony grows. Pick a single colony on the plate and transfer it to 2-5 mL of ...
Embodiment 2
[0067] Embodiment 2 Streptomyces tuberculosis genetically engineered bacteria construction carrying ermE*p-AmphRIV gene
[0068] A) Using the Streptomyces tuberculosis CCTCC NO.M 2017426 genome as a template, design primers amphRIV-F and amphRIV-R for the amphotericin gene cluster regulator gene (AmphRIV, GenBank accession No.CP009313.1SNOD_02710), and amphRIV-F is The forward primer for the AmphRIV gene, amphRIV-R is the reverse primer for AmphRIV, and the AmphRIV fragment is cloned and amplified from the template with a size of about 777bp. It is confirmed by sequencing analysis that it matches the target fragment. The nucleotide sequence is as shown in SEQ ID NO .3, gel recovery and purification of this fragment for future use.
[0069] B) Using the strong erythromycin promoter (ermE*p) as a template (GenBank accession No.HM756283.1), design primers ermE*p-F and ermE*p-R, ermE*p-F is the forward primer for the ermE*p gene, ermE*p-R is the reverse primer for ermE*p, ermE*p ...
Embodiment 3
[0077] Embodiment 3 Streptomyces tuberculosis genetically engineered bacteria construction carrying ermE*p-AraC gene
[0078] A) Using the Streptomyces tuberculosis CCTCC NO.M 2017426 genome as a template, design primers araC-F and araC-R for the global regulator gene (AraC, GenBank accession No.CP009313.1SNOD_12635), araC-F is for the AraC gene The forward primer, araC-R is the reverse primer for AraC. The araC fragment was cloned and amplified from the template with a size of 1227bp. It was confirmed by sequencing analysis that it was consistent with the target fragment. The nucleotide sequence is shown in SEQ ID NO.4. Gel recovery and purification of this fragment for future use.
[0079] B) Using the recombinant plasmid vector pJTU1278-ermE*p-AmphRIV as a template, design primers pE-F and pE-R for the strong promoter and pJTU1278 vector, clone and amplify the pJTU1278-ermE*p fragment with a size of 9598bp from the template Left and right, gel recovery and purification of ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com